Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
09/09/2014
03/09/2014
27/08/2014
19/08/2014
12/08/2014
08/08/2014
08/08/2014
08/08/2014
07/08/2014
06/08/2014
30/07/2014
24/07/2014
24/07/2014
15/07/2014
07/07/2014
04/07/2014
02/07/2014
01/07/2014
27/06/2014
19/06/2014
17/06/2014
16/06/2014
11/06/2014
15/05/2014
14/05/2014
24/04/2014
15/04/2014
04/04/2014
03/04/2014
03/04/2014
17/03/2014
10/03/2014
17/02/2014
17/02/2014
31/01/2014
15/01/2014
24/12/2013
23/12/2013
16/12/2013